CVS - CVS Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
78.55
-0.78 (-0.98%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close79.33
Open79.47
Bid0.00 x 800
Ask0.00 x 1100
Day's Range77.98 - 80.07
52 Week Range60.14 - 83.88
Volume6,155,954
Avg. Volume7,281,696
Market Cap80.027B
Beta (3Y Monthly)1.00
PE Ratio (TTM)26.74
EPS (TTM)2.94
Earnings DateFeb 6, 2019 - Feb 11, 2019
Forward Dividend & Yield2.00 (2.52%)
Ex-Dividend Date2018-10-23
1y Target Est92.63
Trade prices are not sourced from all markets
  • MARKETS: Oil rebounding off recent lows
    Yahoo Finance Video4 days ago

    MARKETS: Oil rebounding off recent lows

    Yahoo Finance’s Seana Smith breaks down the action on Wall Street.

  • There will be increased awareness of how much innovation ...
    CNBC Videos12 days ago

    There will be increased awareness of how much innovation ...

    John Sculley, RX Advance chairman and former CEO of Apple, joins 'Squawk Alley' to discuss how the healthcare industry is going to change following the midterm elections.

  • PR Newswire5 days ago

    CVS Health Applauds FDA's Announcement to Restrict Flavored Tobacco Products

    WOONSOCKET, R.I., Nov. 15, 2018 /PRNewswire/ -- CVS Health (CVS), the nation's first and only national pharmacy chain to have eliminated the sale of tobacco products from its retail stores, today announced its support for the U.S. Food and Drug Administration's plans to restrict access to flavored tobacco and e-cigarette products in the retail setting and impose stricter age-verification requirements for online sales. In addition to eliminating the sale of tobacco products in 2014, CVS Health has never sold e-cigarettes or vaping devices in any of its CVS Pharmacy locations. "We applaud the FDA's decision to restrict access to flavored tobacco and e-cigarette products, which have been expertly marketed and targeted at teens and young adults and has contributed to a dramatic rise in e-cigarette use among high school students," said Troyen Brennan, M.D., M.P.H. and Chief Medical Officer for CVS Health.

  • CVS Health Teams Up with Philadelphia Job Corps, Philadelphia Works and Philadelphia Youth Network to Open New Mock Pharmacy for Aspiring Pharmacy Technicians
    PR Newswire5 days ago

    CVS Health Teams Up with Philadelphia Job Corps, Philadelphia Works and Philadelphia Youth Network to Open New Mock Pharmacy for Aspiring Pharmacy Technicians

    PHILADELPHIA, Nov. 15, 2018 /PRNewswire/ -- In its continuing commitment to expand work-based learning and externship opportunities for students, CVS Health has announced a new collaboration with Philadelphia Job Corps, Philadelphia Works and Philadelphia Youth Network to deliver a pre-apprenticeship and apprenticeship program for pharmacy technicians in the greater Philadelphia area.

  • Apple, Pot Stocks Show Sickly Losses; Will These 7 Industry Groups Lead Market Uptrend?
    Investor's Business Daily6 days ago

    Apple, Pot Stocks Show Sickly Losses; Will These 7 Industry Groups Lead Market Uptrend?

    Pot stocks and Apple lead the broad market decline. Institutions return to consumer-oriented stocks.

  • PR Newswire6 days ago

    Coram CVS Specialty® Home Infusion Services Awarded Home Care Accreditation from The Joint Commission

    WOONSOCKET, R.I., Nov. 14, 2018 /PRNewswire/ -- Coram CVS Specialty® Home Infusion Services (Coram), a CVS Health (CVS) company, today announced it has earned The Joint Commission's Gold Seal of Approval® for Home Care Accreditation. The Gold Seal of Approval® is a symbol of quality that reflects Coram's commitment to providing safe and effective care. As part of the evaluation process, Coram underwent rigorous onsite surveys to ensure compliance with home care standards, including the provision of care, treatment and services, emergency management, human resources, among other standards.

  • ACCESSWIRE7 days ago

    4 Healthcare Stocks Investors Are Watching In November

    Eighty-three percent of healthcare organizations responding to an American Telemedicine Association* poll said they are highly likely to invest in telehealth with operational efficiency and convenience in mind. Of the 171 healthcare executives participating in the annual ATA Executive Leadership Survey, 88% of those who are likely to purchase telehealth tools are planning to do so. "This executive leadership survey confirms undeniably today's leaders view telemedicine as a major driver in transforming healthcare," said Jonathan Linkous, CEO, American Telemedicine Association.

  • Walmart, Home Depot adopt health insurer tactic in drug copay battle
    Reuters7 days ago

    Walmart, Home Depot adopt health insurer tactic in drug copay battle

    Walmart (WMT.N) and Home Depot (HD.N), two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications. Large U.S. companies have started tightly managing how employees and their family members use these popular discount, or copay, cards for everything from multiple sclerosis treatments to widely-used rheumatoid arthritis medications sold through a specialty pharmacy.

  • CVS Health (CVS) Gains As Market Dips: What You Should Know
    Zacks7 days ago

    CVS Health (CVS) Gains As Market Dips: What You Should Know

    CVS Health (CVS) closed at $80.34 in the latest trading session, marking a +0.64% move from the prior day.

  • 5 Stocks to Sell After the Midterm Election
    InvestorPlace7 days ago

    5 Stocks to Sell After the Midterm Election

    After Democrats obtained a narrow majority in the House of Representatives in the midterm elections, both House Democrats and President Trump will likely be looking to make at least some deals. To retain their majority, House Democrats will have to convince moderate voters in the swing districts that Democrats narrowly won that they are moderate and can be productive. For his part, President Trump will likely have to convince at least some moderate voters, i.e., centrist suburban women and independents that he can make deals that will make the country and their lives better.

  • Your Private Data Is Quietly Leaking Online, Thanks to a Basic Web Security Error
    Bloomberg8 days ago

    Your Private Data Is Quietly Leaking Online, Thanks to a Basic Web Security Error

    The personal information of American charity donors, political party supporters, and online shoppers, has continued to quietly leak onto the internet as a result of poor website security practices, new research shows. As many as one in five e-commerce sites in the U.S. are still leaving their customers exposed, Philadelphia-based search marketing company Seer Interactive said Monday. "If you were one of the 50 largest e-commerce sites you’d think you’d have this under wraps, and that’s the most troubling thing," said Adam Melson, a director at Seer.

  • 10 Best Value Stocks to Buy Now
    Kiplinger8 days ago

    10 Best Value Stocks to Buy Now

    Value stocks are en vogue again. As recently as the end of May, stock prognosticators were calling for the Dow Jones Industrial Average to hit 30,000. Some suggested the Dow would reach that number by the end of 2018. Growth looked in, and slow-but-steady value picks were out. That was until October's bout of nauseating volatility. Thanks to a trade war with China, higher interest rates, problematic technology earnings and worries that a decade-long bull market is primed to lose its legs, the Nasdaq hit correction mode and the Standard & Poor's 500-stock index came close. Growth stocks - especially smaller companies - have been hammered, while large-cap value stocks have gained favor among investors looking for a little protection to go with their upside potential. Here are 10 large value stocks to buy now, with the expectation that they should thrive compared to their growthy brethren in a tumultuous environment. SEE ALSO: 101 Best Dividend Stocks to Buy for 2019 and Beyond

  • ACCESSWIRE11 days ago

    Healthcare Stocks Shift Focus To eHealth Growth Trends; Premier Health Group, Inc. (PHGRF) (PHGI), CVS Health, Allscripts

    With this in mind, a number of public companies are getting actively involved in capturing early market share including Premier Health Group, Inc. (PHGRF) (PHGI), CVS Health (CVS) and Allscripts (MDRX). Premier Health Group, Inc. (PHGRF) (PHGI) entered the primary care clinic and healthcare technology business via the HealthVue transaction. Premier obtained access to a group of four Greater Vancouver-based fully integrated, paperless and electronic-medical-record-based medical clinics with a 10-year history, 22 healthcare professionals and over 100,000 active patients.

  • Investor's Business Daily14 days ago

    CVS Health Earnings Top Estimates But No Boost To Outlook

    In the last CVS Health earnings report before its Aetna takeover closes, the drugstore and pharmacy benefit manager giant edged past views. CVS stock rose.

  • Investor's Business Daily12 days ago

    Humana Hits Buy Point On Earnings; Election Results Send Health Insurers Soaring

    Humana earnings, the Democratic House takeover and Medicaid expansions in 3 states sent health insurers soaring Wednesday. Humana and several peers hit buy points.

  • Thomson Reuters StreetEvents12 days ago

    Edited Transcript of CVS earnings conference call or presentation 6-Nov-18 1:30pm GMT

    Q3 2018 CVS Health Corp Earnings Call

  • CVS: Analysts’ Ratings and Target Prices
    Market Realist12 days ago

    CVS: Analysts’ Ratings and Target Prices

    CVS Health (CVS) posted stronger-than-expected third-quarter results on November 6. A few analysts raised the target prices on CVS stock. RBC increased its target price to $100 per share on CVS from $99. Meanwhile, Baird raised the target price to $77 from $73. Analysts have a consensus target price of $89.55 per share on CVS, which indicates an upside potential of 15.0% based on its closing price of $77.90 on November 6.

  • What Drove CVS Health’s Bottom Line in Q3 2018?
    Market Realist13 days ago

    What Drove CVS Health’s Bottom Line in Q3 2018?

    CVS Health (CVS) maintained its streak of exceeding Wall Street analysts’ bottom-line expectation during the third quarter. CVS posted adjusted earnings of $1.73, which beat analysts’ estimate of $1.71 and increased 15.3% on a YoY (year-over-year) basis. The following graph shows that CVS has reported better-than-expected earnings for five consecutive quarters.

  • CVS’s Q3 Sales Beat the Estimate
    Market Realist13 days ago

    CVS’s Q3 Sales Beat the Estimate

    CVS Health (CVS) reported stronger-than-expected third-quarter sales. The company reported net sales of $47.3 billion, which beat analysts’ estimate of $47.2 billion and increased 2.4% on a YoY (year-over-year) basis. Increased net new business, the growing adoption of Maintenance Choice offerings, brand inflation, and higher same-store prescription volumes drove the company’s third-quarter net sales growth.

  • PR Newswire13 days ago

    MinuteClinic Opens First Walk-in Medical Clinic in San Francisco

    WOONSOCKET, R.I., Nov. 7, 2018 /PRNewswire/ -- A new MinuteClinic walk-in medical clinic has opened inside the CVS Pharmacy store at 1900 19th Avenue in San Francisco, California, providing the community with convenient access to common health care services. The clinic is the first MinuteClinic location in the city of San Francisco and will be open seven days a week with no appointment necessary. MinuteClinic is the retail medical clinic of CVS Health (CVS), the largest pharmacy health care provider in the United States.

  • CVS Stock Rose 5.7% Due to Strong Third-Quarter Results
    Market Realist13 days ago

    CVS Stock Rose 5.7% Due to Strong Third-Quarter Results

    CVS Health (CVS) reported better-than-expected third-quarter results on November 6. The company’s top and bottom line exceeded analysts’ estimates due to the strong comp script growth, higher drug prices, and growth in claim volumes. However, pricing and reimbursement pressure remained a drag.